PIPELINE WATCH Basiliximab loses SPC protection in the EU pril brings the expiry of supplementary protection certificates (SPCs) for Novartis’ monoclonal antibody (mAb) Simulect (basiliximab) in major European Union ( - Basiliximab - Document - PDFSEARCH.IO

First Page	Meta Content
	PIPELINE WATCH Basiliximab loses SPC protection in the EU pril brings the expiry of supplementary protection certificates (SPCs) for Novartis’ monoclonal antibody (mAb) Simulect (basiliximab) in major European Union ( Add to Reading List Document Date: 2013-04-23 21:06:39 Open Document File Size: 49,68 KB Share Result on Facebook

PIPELINE WATCH Basiliximab loses SPC protection in the EU pril brings the expiry of supplementary protection certificates (SPCs) for Novartis’ monoclonal antibody (mAb) Simulect (basiliximab) in major European Union (Add to Reading List